Completion of Sale of Admiral trademarks in the...
EKF DIAGNOSTICS HOLDINGS PLC
Completion of Sale of Admiral trademarks in the Americas
EKF Diagnostics Holdings plc (AIM: EKF) announces that, pursuant to the
announcement released on 24 December 2010, it has received the cash
consideration of US$774,000 in relation to the sale of the rights to the
Admiral sports brand in the Americas. As announced on 24 December 2010,
completion of the disposal of the remaining rights in the Admiral sportswear
brand (now being the Admiral trademarks in certain European territories) is
expected to complete on 28 January 2011.
Enquiries:
EKF Diagnostics Holdings plc
Julian Baines, CEO Mob: 07788 420 859
Paul Foulger, FD Tel: 020 7823 1733
Zeus Capital
Nominated Adviser and Joint Broker Tel: 0161 831 1512
Ross Andrews
Tom Rowley
Matrix Corporate Capital LLP Tel: 020 3206 7000
Joint Broker
Robert Naylor
Stephen Waterman
Walbrook PR Tel: 020 7933 8780
Paul McManus Mob: 07980 541 893 paul.mcmanus@walbrookpr.com
-1-
24/02/1970 06:0320/01/2011 15:43 SXS 2175936.1
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.